{"disease":{"id":"time","name":"time"},"drugs":{"marketed":[{"drug_id":"copper","indication_name":"nighttime cramps in legs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arnicare Leg Cramps","generic_name":"COPPER","company_name":"Sebela Womens Hlth","drug_phase":"marketed","molecular_target":"","drug_class":"Copper-containing Intrauterine Device [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"copper","indication_name":"nighttime cramps in thighs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arnicare Leg Cramps","generic_name":"COPPER","company_name":"Sebela Womens Hlth","drug_phase":"marketed","molecular_target":"","drug_class":"Copper-containing Intrauterine Device [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"copper","indication_name":"nighttime cramps in calves","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arnicare Leg Cramps","generic_name":"COPPER","company_name":"Sebela Womens Hlth","drug_phase":"marketed","molecular_target":"","drug_class":"Copper-containing Intrauterine Device [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"copper","indication_name":"nighttime cramps in feet","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arnicare Leg Cramps","generic_name":"COPPER","company_name":"Sebela Womens Hlth","drug_phase":"marketed","molecular_target":"","drug_class":"Copper-containing Intrauterine Device [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"copper","indication_name":"nighttime cramps in toes","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arnicare Leg Cramps","generic_name":"COPPER","company_name":"Sebela Womens Hlth","drug_phase":"marketed","molecular_target":"","drug_class":"Copper-containing Intrauterine Device [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Stentriever Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Stentriever Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Solitaire FR Revascularization Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Stentriever Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Stentriever Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Solitaire FR Revascularization Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Stentriever Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Stentriever Device and a Trevo Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Trevo Device and a Penumbra System","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Stentriever Device and a Trevo Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Stentriever Device and a Penumbra System","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Solitaire FR Revascularization Device and a Trevo Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Solitaire FR Revascularization Device and a Penumbra System","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Stentriever Device and a Trevo Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Stentriever Device and a Penumbra System","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Stentriever Device and a Trevo Device and a Penumbra System","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Stentriever Device and a Penumbra System","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Solitaire FR Revascularization Device and a Trevo Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"best-available-treatment","indication_name":"Acute Ischemic Stroke with Malignant Cerebral Edema in the Posterior Circulation and a Baseline NIH Stroke Scale Score of 10 or Greater and a Time to Treatment of 4.5 to 6 Hours and a Mechanical Thrombectomy Device and a Stentriever Device and a Trevo Device","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Best Available Treatment","generic_name":"best-available-treatment","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":52,"revenue":null,"mechanism":"Not specified on Wikipedia"},{"drug_id":"theophyllin","indication_name":"Asthma night-time symptoms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Theophyllin","company_name":"University of Bergen","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"diprophylline","indication_name":"Asthma night-time symptoms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diphyllin","generic_name":"diprophylline","company_name":"","drug_phase":"marketed","molecular_target":"cAMP-specific 3',5'-cyclic phosphodiesterase 4B","drug_class":"diprophylline","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"aminophyllin","indication_name":"Asthma night-time symptoms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aminophyllin","company_name":"University of Padova","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":36,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05558423","title":"ZOE Health Study: The Intermittent Fasting Study","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150000,"lead_sponsor_name":"Zoe Global Limited","has_results":false},{"nct_id":"NCT06527703","title":"An International Prospective, Observational, Multi-centre Study on the Duration of Pre-operative Liquid Fasting","phase":"","overall_status":"COMPLETED","enrollment_count":5100,"lead_sponsor_name":"Mater Dei Hospital, Malta","has_results":false},{"nct_id":"NCT06336525","title":"Adult Sleep Health in the Rural Appalachia and Mississippi Delta Region and Its Relationships With Cardiometabolic Health Disparities.","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3680,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT06162481","title":"Admission Time and Outcomes of Patients Admitted to Intensive Care Unit in a Tertiary Level Teaching Hospital","phase":"","overall_status":"COMPLETED","enrollment_count":3242,"lead_sponsor_name":"Tribhuvan University Teaching Hospital, Institute Of Medicine.","has_results":false},{"nct_id":"NCT03451604","title":"PAC Time Assessment","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT06480617","title":"Observational, Bivariate Analysis of Clinical Big Data in Patients With Cervical Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Anhui Provincial Hospital","has_results":false},{"nct_id":"NCT06306092","title":"Promoting Teenage Sleep for Improved Mental Health and School Performance","phase":"NA","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Kristianstad University","has_results":false},{"nct_id":"NCT04068428","title":"Reproductive Health of Couples of Childbearing Age: a Community Based Prospective Cohort Study","phase":"","overall_status":"COMPLETED","enrollment_count":2313,"lead_sponsor_name":"Guangzhou Women and Children's Medical Center","has_results":false},{"nct_id":"NCT03397940","title":"Role of Structured Days on Weight Gain","phase":"","overall_status":"COMPLETED","enrollment_count":2279,"lead_sponsor_name":"University of South Carolina","has_results":false},{"nct_id":"NCT04602299","title":"Setting the Shortest Examination Time of Gastroscopy to Improve the Detection Rate of Upper Gastrointestinal Tumors","phase":"NA","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT03094975","title":"A Multicenter Registry Study of Aneurysmal SAH","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Jian-min Liu","has_results":false},{"nct_id":"NCT06012955","title":"Study on the Effect of Target-controlled Infusion for General Anesthesia in Cardiac Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT03991416","title":"Understanding Your Baby: A Parallel Group Study of a Universal Parenting Support Program","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1737,"lead_sponsor_name":"University of Copenhagen","has_results":false},{"nct_id":"NCT03317639","title":"Improving In-hospital Stroke Service Utilisation in China","phase":"NA","overall_status":"COMPLETED","enrollment_count":1634,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT05940675","title":"Generation Healthy Kids: A Cluster-randomized Trial of a Multi-component, Multi-setting Intervention","phase":"NA","overall_status":"COMPLETED","enrollment_count":1372,"lead_sponsor_name":"University of Copenhagen","has_results":false},{"nct_id":"NCT01537393","title":"Cornea Preservation Time Study","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1174,"lead_sponsor_name":"Case Western Reserve University","has_results":true},{"nct_id":"NCT07199660","title":"Reactions to Social Media Warning Labels Among Teens and Young Adults","phase":"NA","overall_status":"COMPLETED","enrollment_count":1012,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT05992012","title":"Myocardial Infarction Triggers and Onset in Jordan Study 2","phase":"","overall_status":"TERMINATED","enrollment_count":1000,"lead_sponsor_name":"Jordan Collaborating Cardiology Group","has_results":false},{"nct_id":"NCT03141268","title":"Rapid Orocecal Transit Time and Fermentation in IBS.","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Uppsala University","has_results":false},{"nct_id":"NCT05256459","title":"Clinical Intervention Strategy for High-risk Group of Hepatitis B Related Hepatocellular Carcinoma","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Zhang Dazhi,MD","has_results":false},{"nct_id":"NCT07112469","title":"The Effectiveness of Intervention to Increase Physical Activity and Sleep Time of Junior High School Students","phase":"NA","overall_status":"COMPLETED","enrollment_count":948,"lead_sponsor_name":"Pham Ngoc Thach University of Medicine","has_results":false},{"nct_id":"NCT04395287","title":"Prospective Associations Between Screen Media Use and Physical Activity in Preschool Children","phase":"","overall_status":"COMPLETED","enrollment_count":887,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT05973890","title":"Community-based Communication for Blood Donation in Ghana","phase":"NA","overall_status":"COMPLETED","enrollment_count":882,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT03115437","title":"Effects of Shoe Cushioning and Body Mass on Injury Risk in Running","phase":"NA","overall_status":"COMPLETED","enrollment_count":874,"lead_sponsor_name":"Luxembourg Institute of Health","has_results":false},{"nct_id":"NCT01964430","title":"Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the \"Apact\" Study)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":866,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT06579963","title":"Assessing the Effect of Cool Roofs on Health Using Smartwatches","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":800,"lead_sponsor_name":"Aditi Bunker","has_results":false},{"nct_id":"NCT04885283","title":"Factors Affecting the Time to Start Postoperative Chemotherapy in Colorectal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Inonu University","has_results":false},{"nct_id":"NCT06831006","title":"Assessing the Effect of Cool Roofs on Health Using Smartwatches in Colima, Mexico","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":800,"lead_sponsor_name":"University of Auckland, New Zealand","has_results":false},{"nct_id":"NCT04275765","title":"Community Enabled Readiness for First 1000 Days Learning Ecosystem","phase":"NA","overall_status":"UNKNOWN","enrollment_count":750,"lead_sponsor_name":"KK Women's and Children's Hospital","has_results":false},{"nct_id":"NCT02567006","title":"SMS Mobile Technology to Improve Early Childhood Vaccine Coverage in Guatemala","phase":"NA","overall_status":"COMPLETED","enrollment_count":720,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT04656912","title":"Hyperbaric Oxygen Therapy Initiation Time in Acute Carbon Monoxide Poisoning","phase":"","overall_status":"COMPLETED","enrollment_count":706,"lead_sponsor_name":"Wonju Severance Christian Hospital","has_results":false},{"nct_id":"NCT06163495","title":"Screen Free Time With Friends: a Cluster-randomized Controlled Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":685,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT03471377","title":"Improving Planned Surgical Case Duration Accuracy by Leveraging the EHR and Predictive Modeling","phase":"","overall_status":"COMPLETED","enrollment_count":683,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT05188547","title":"Information Retention After Video (Augmented) Preoperative Anesthesiological Education","phase":"NA","overall_status":"COMPLETED","enrollment_count":677,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT07273890","title":"Real-time Feedback of Red-out Within Colonoscopy Intubation","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":576,"lead_sponsor_name":"The First Affiliated Hospital of Anhui Medical University","has_results":false},{"nct_id":"NCT03360084","title":"Systemic Air Embolism After CT-guided Lung Biopsy","phase":"","overall_status":"COMPLETED","enrollment_count":559,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT06705712","title":"Physical Activity, Fertility, and Spontaneous Abortion in Danish Couples Trying to Conceive","phase":"NA","overall_status":"RECRUITING","enrollment_count":530,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT07175259","title":"Relation of Total Ischemic Time to Repolarization Indices and Their Impact on Outcomes Among STEMI Patients Undergoing Primary PCI","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07382076","title":"Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Abbott Point of Care","has_results":false},{"nct_id":"NCT04711382","title":"The Use of Faster Acting Aspart in Type 1 Diabetes Patients","phase":"","overall_status":"COMPLETED","enrollment_count":438,"lead_sponsor_name":"University Hospital, Antwerp","has_results":false},{"nct_id":"NCT06755424","title":"GI Symptoms in Infants Fed Goat Milk-based Infant Formula","phase":"","overall_status":"COMPLETED","enrollment_count":425,"lead_sponsor_name":"Ausnutria Hyproca B.V.","has_results":false},{"nct_id":"NCT06161948","title":"Time-restricted Enteral Nutrition Versus Continuous Enteral Nutrition in Patients With Severe Stroke","phase":"NA","overall_status":"COMPLETED","enrollment_count":420,"lead_sponsor_name":"First Affiliated Hospital of Wannan Medical College","has_results":false},{"nct_id":"NCT05789966","title":"Fullscale_Intervention Study: Genetic Risk Communication in Coronary Heart Disease and Wearables","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":414,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT06898008","title":"Characterization of Children with Complaints of Excessive Daytime Sleepiness","phase":"","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05939960","title":"Application of a New Type of Whole Blood Coagulation Time Measurement in Evaluating the Hypercoagulable State of Malignant Tumors","phase":"","overall_status":"UNKNOWN","enrollment_count":354,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT05579158","title":"Effects of Time-restricted Eating Supported by Mobile Technology in Patients With Non-alcoholic Fatty Liver Disease: Randomized Controlled Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":337,"lead_sponsor_name":"Hanyang University","has_results":false},{"nct_id":"NCT03402516","title":"Comparison of Two Bipolar Resector in Less Than 3cm Myoma Resection","phase":"NA","overall_status":"UNKNOWN","enrollment_count":308,"lead_sponsor_name":"Bicetre Hospital","has_results":false},{"nct_id":"NCT06364566","title":"Exploring the Optimal Timing of Minimally Invasive Surgery for Esophageal Squamous Cell Carcinoma","phase":"NA","overall_status":"COMPLETED","enrollment_count":303,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT07311434","title":"Sleep and Morning Wellbeing Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Athletic Greens International","has_results":false},{"nct_id":"NCT06236217","title":"Prediction of Spinal Anesthesia-Induced Hypotension in Cesarian Section: Carotid Artery-Corrected Flow Time Versus Cardiometry","phase":"NA","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Tanta University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}